| Ident. | Authors (with country if any) | Title |
|---|
| 000023 (2012) |
Kelly Bertram [Australie] ; David R. Williams [Australie] | Visual hallucinations in the differential diagnosis of parkinsonism |
| 000048 (2012) |
Manu Sharma ; John P A. Ioannidis [États-Unis] ; Jan O. Aasly [Norvège] ; Grazia Annesi [Italie] ; Alexis Brice [France] ; Lars Bertram [Allemagne] ; Maria Bozi [Grèce] ; Maria Barcikowska [Pologne] ; David Crosiers [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Maurizio F. Facheris ; Matthew Farrer [Canada] ; Gaetan Garraux ; Suzana Gispert [Allemagne] ; Georg Auburger ; Carles Vilari O-Güell [Canada] ; Georgios M. Hadjigeorgiou [Grèce] ; Andrew A. Hicks ; Nobutaka Hattori [Japon] ; Beom S. Jeon [Corée du Sud] ; Zygmunt Jamrozik [Pologne] ; Anna Krygowska-Wajs [Pologne] ; Suzanne Lesage [France] ; Christina M. Lill [Grèce, Allemagne] ; Juei-Jueng Lin [Taïwan] ; Timothy Lynch [Irlande (pays)] ; Peter Lichtner [Allemagne] ; Anthony E. Lang [Canada] ; Cecile Libioulle [Canada] ; Miho Murata [Japon] ; Vincent Mok [Hong Kong] ; Barbara Jasinska-Myga [Pologne] ; George D. Mellick [Australie] ; Karen E. Morrison [Royaume-Uni] ; Thomas Meitnger [Allemagne] ; Alexander Zimprich [Autriche] ; Grzegorz Opala [Allemagne] ; Peter P. Pramstaller ; Irene Pichler ; Sung Sup Park [Allemagne] ; Aldo Quattrone [Italie] ; Ekaterina Rogaeva [Canada] ; Owen A. Ross [États-Unis] ; Leonidas Stefanis [Grèce] ; Joanne D. Stockton [Royaume-Uni] ; Wataru Satake [Japon] ; Peter A. Silburn [Australie] ; Tim M. Strom [Allemagne, Canada] ; Jessie Theuns [Belgique] ; Eng- King Tan [Singapour] ; Tatsushi Toda [Japon] ; Hiroyuki Tomiyama [Japon] ; Ryan J. Uitti [États-Unis] ; Christine Van Broeckhoven [Belgique] ; Karin Wirdefeldt ; Zbigniew Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Harumi S. Yomono [Japon] ; Kuo-Chu Yueh [Taïwan] ; Yi Zhao ; Thomas Gasser ; Demetrius Maraganore [États-Unis] ; Rejko Krüger | A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants |
| 000063 (2012) |
Gregory L. Willis [Australie] ; Cleo Moore [Australie] ; Stuart M. Armstrong [Australie] | Breaking away from dopamine deficiency: an essential new direction for Parkinson’s disease |
| 000086 (2011) |
W G J. Reid [Australie] ; M A Hely [Australie] ; J G L. Morris [Australie] ; C. Loy [Australie] ; G M Halliday [Australie] | Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study) |
| 000092 (2011) |
Michael Eller [Australie] ; David R. Williams | α-Synuclein in Parkinson disease and other neurodegenerative disorders |
| 000097 (2011) |
James M. Shine [Australie] ; Glenda M. Halliday [Australie] ; Sharon L. Naismith [Australie] ; Simon J. G. Lewis [Australie] | Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks? |
| 000102 (2011) |
Samantha A. Hollingworth [Australie] ; Amanda Rush [Australie] ; Wayne D. Hall [Australie] ; Mervyn J. Eadie [Australie] | Utilization of anti‐Parkinson drugs in Australia: 1995–2009 |
| 000112 (2011) |
Gabriella Constantinescu [Australie] ; Deborah Theodoros [Australie] ; Trevor Russell [Australie] ; Elizabeth Ward [Australie] ; Stephen Wilson [Australie] ; Richard Wootton [Royaume-Uni] | Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non‐inferiority trial |
| 000185 (2011) |
Jamie M. Sheard ; Susan Ash [Australie] ; Peter A. Silburn [Australie] ; Graham K. Kerr [Australie] | Prevalence of malnutrition in Parkinson's disease: a systematic review |
| 000227 (2011) |
Sharon L. Naismith [Australie] ; Zoë Terpening [Australie] ; James M. Shine [Australie] ; Simon J. G. Lewis [Australie] | Neuropsychological functioning in Parkinson's disease: Differential relationships with self‐reported sleep‐wake disturbances |
| 000237 (2011) |
Alison Kan [Australie] ; Michael C. Dove [Australie] ; Wayne A. O'Connor [Australie] ; Sham V. Nair [Australie] ; David A. Raftos [Australie] | Mortality in single‐pair mating families of QX disease‐resistant and wild‐type Sydney rock oysters (Saccostrea glomerata) |
| 000253 (2011) |
Glenda Halliday [Australie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Matthew Stern [États-Unis] | Milestones in Parkinson's disease—Clinical and pathologic features |
| 000287 (2011) |
Alexis Elbaz [France] ; Owen A. Ross [États-Unis] ; John P. A. Ioannidis [Grèce, États-Unis] ; Alexandra I. Soto-Ortolaza [États-Unis] ; Frédéric Moisan [France] ; Jan Aasly [Norvège] ; Grazia Annesi [Italie] ; Maria Bozi [Grèce] ; Laura Brighina [Italie] ; Marie-Christine Chartier-Harlin [France] ; Alain Destée [France] ; Carlo Ferrarese [Italie] ; Alessandro Ferraris [Italie] ; J. Mark Gibson [Irlande (pays)] ; Suzana Gispert [Allemagne] ; Georgios M. Hadjigeorgiou [Grèce] ; Barbara Jasinska-Myga [Pologne] ; Christine Klein [Allemagne] ; Rejko Krüger [Allemagne] ; Jean-Charles Lambert [France] ; Katja Lohmann [Allemagne] ; Simone Van De Loo [Allemagne] ; Marie-Anne Loriot [France] ; Timothy Lynch [Irlande (pays)] ; George D. Mellick [Australie] ; Eugénie Mutez [France] ; Christer Nilsson [Suède] ; Grzegorz Opala [Pologne] ; Andreas Puschmann [Suède] ; Aldo Quattrone [Italie] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Leonidas Stefanis [Grèce] ; Ryan J. Uitti [États-Unis] ; Enza Maria Valente [Italie] ; Carles Vilari O-Güell [États-Unis, Canada] ; Karin Wirdefeldt [Suède] ; Zbigniew K. Wszolek [États-Unis] ; Georgia Xiromerisiou [Grèce] ; Demetrius M. Maraganore [États-Unis] ; Matthew J. Farrer [États-Unis, Canada] | Independent and joint effects of the MAPT and SNCA genes in Parkinson disease |
| 000291 (2011) |
Polly Ambermoon [Australie] ; Adrian Carter [Australie] ; Wayne D. Hall [Australie] ; Nadeeka N. W. Dissanayaka [Australie] ; John D. O'Sullivan [Australie] | Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field |
| 000303 (2011) |
Glenda M. Halliday [Australie] ; Claire H. Stevens [Australie] | Glia: Initiators and progressors of pathology in Parkinson's disease |
| 000321 (2011) |
Mehrnaz Shoushtarian [Australie] ; Anna Murphy [Australie] ; Robert Iansek [Australie] | Examination of central gait control mechanisms in Parkinson's disease using movement‐related potentials |
| 000331 (2011) |
Y. J. Zhao [Singapour] ; L. C. S. Tan ; S. C. Li [Singapour, Australie] ; W. L. Au ; S. H. Seah ; P. N. Lau ; N. Luo [Singapour] ; H. L. Wee [Singapour] | Economic burden of Parkinson’s disease in Singapore |
| 000350 (2011) |
Emma C. Schofield [Australie] ; John R. Hodges [Australie] ; Virginia Macdonald [Australie] ; Nicholas J. Cordato [Australie] ; Jillian J. Kril [Australie] ; Glenda M. Halliday [Australie] | Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy |
| 000365 (2011) |
Yun Ju Christine Song [Australie] ; Yue Huang [Australie] ; Glenda Margaret Halliday [Australie] | Clinical correlates of similar pathologies in parkinsonian syndromes |
| 000388 (2011) |
Natalie E. Allen [Australie] ; Catherine Sherrington [Australie] ; Serene S. Paul [Australie] ; Colleen G. Canning [Australie] | Balance and falls in Parkinson's disease: A meta‐analysis of the effect of exercise and motor training |
| 000411 (2011) |
Kitty K. Wong [Australie] ; Jane E. Alty [Australie] ; Amanda G. Goy [Australie] ; Sanjay Raghav [Australie] ; David C. Reutens [Australie] ; Peter A. Kempster [Australie] | A randomized, double‐blind, placebo‐controlled trial of levetiracetam for dyskinesia in Parkinson's disease |
| 000429 (2010) |
Deborah Lehmann [Australie] ; Judith Willis [Australie] ; Hannah C. Moore [Australie] ; Carolien Giele [Australie] ; Denise Murphy [Australie] ; Anthony D. Keil [Australie] ; Catherine Harrison [Australie] ; Kathy Bayley [Australie] ; Michael Watson [Australie] ; Peter Richmond [Australie] | The Changing Epidemiology of Invasive Pneumococcal Disease in Aboriginal and Non-Aboriginal Western Australians from 1997 through 2007 and Emergence of Nonvaccine Serotypes |
| 000504 (2010) |
Tom H. Johnston [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Juha-Matti Savola [Suisse] ; Jonathan M. Brotchie [Canada] | The α2 adrenergic antagonist fipamezole improves quality of levodopa action in Parkinsonian primates |
| 000512 (2010) |
Glenda Margaret Halliday [Australie] ; Heather Mccann [Australie] | The progression of pathology in Parkinson's disease |
| 000577 (2010) |
Ying Jiao Zhao ; Hwee Lin Wee ; Yiong-Huak Chan ; Soo Hoon Seah ; Wing Lok Au ; Puay Ngoh Lau ; Emmanuel Camara Pica ; Shu Chuen Li [Australie] ; Nan Luo ; Louis C. S. Tan | Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times |
| 000622 (2010) |
Evangelos Evangelou [Grèce, Suisse] ; Demetrius M. Maraganore [États-Unis] ; Grazia Annesi [Italie] ; Laura Brighina [Italie] ; Alexis Brice [France] ; Alexis Elbaz [France] ; Carlo Ferrarese [Italie] ; Georgios M. Hadjigeorgiou [Grèce] ; Rejko Krueger [Allemagne] ; Jean-Charles Lambert [France] ; Suzanne Lesage [France] ; Katerina Markopoulou [Grèce] ; George D. Mellick [Australie] ; Bram Meeus [Belgique] ; Nancy L. Pedersen [Suède] ; Aldo Quattrone [Italie] ; Christine Van Broeckhoven [Belgique] ; Manu Sharma [Allemagne] ; Peter A. Silburn [Australie] ; Eng-King Tan [Singapour] ; Karin Wirdefeldt [Suède] ; John P. A. Ioannidis [Grèce, États-Unis] | Non‐replication of association for six polymorphisms from meta‐analysis of genome‐wide association studies of Parkinson's disease: Large‐scale collaborative study |
| 000681 (2010) |
Sean S. O'Sullivan [Royaume-Uni] ; Atbin Djamshidian [Royaume-Uni, Autriche] ; Zeshan Ahmed [Royaume-Uni] ; Andrew H. Evans [Australie] ; Andrew D. Lawrence [Royaume-Uni] ; Janice L. Holton [Royaume-Uni] ; Tamas Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Impulsive‐compulsive spectrum behaviors in pathologically confirmed progressive supranuclear palsy |
| 000713 (2010) |
Kay Seidel [Allemagne] ; Ludger Schöls [Allemagne] ; Silke Nuber [Allemagne] ; Elisabeth Petrasch-Parwez [Allemagne] ; Kristin Gierga [Allemagne] ; Zbigniew Wszolek [États-Unis] ; Dennis Dickson [États-Unis] ; Wei P. Gai [Australie] ; Antje Bornemann [Allemagne] ; Olaf Riess [Allemagne] ; Abdelhaq Rami [Allemagne] ; Wilfried F. A. Den Dunnen [Pays-Bas] ; Thomas Deller [Allemagne] ; Udo Rüb [Allemagne] ; Rejko Krüger [Allemagne] | First appraisal of brain pathology owing to A30P mutant alpha‐synuclein |
| 000770 (2010) |
Andrew H. Evans [Australie, Royaume-Uni] ; Andrew D. Lawrence [Royaume-Uni] ; Silke Appel Cresswell [Canada] ; Regina Katzenschlager [Royaume-Uni, Autriche] ; Andrew Lees (neurologue) [Royaume-Uni] | Compulsive use of dopaminergic drug therapy in Parkinson's disease: Reward and anti‐reward |
| 000807 (2010) |
Gabriella Constantinescu [Australie] ; Deborah Theodoros [Australie] ; Trevor Russell [Australie] ; Elizabeth Ward [Australie] ; Stephen Wilson [Australie] ; Richard Wootton [Royaume-Uni] | Assessing disordered speech and voice in Parkinson's disease: a telerehabilitation application |
| 000814 (2010) |
Nadeeka N. W. Dissanayaka [Australie] ; Anna Sellbach [Australie] ; Sally Matheson [Australie] ; John D. O'Sullivan [Australie] ; Peter A. Silburn [Australie] ; Gerard J. Byrne [Australie] ; Rodney Marsh [Australie] ; George D. Mellick [Australie] | Anxiety disorders in Parkinson's disease: Prevalence and risk factors |
| 000830 (2010) |
Lukasz Szumowski [Pologne] ; Ewa Szufladowicz [Pologne] ; Michał Orczykowski [Pologne] ; Robert Bodalski [Pologne] ; Paweł Derejko [Pologne] ; Andrzej Przybylski [Pologne] ; Piotr Urbanek [Pologne] ; Mariusz Ku Mierczyk [Pologne] ; Edward Ko Luk [Pologne] ; Frederic Sacher [France] ; Prashanthan Sanders [Australie] ; Joanna Dangel [Pologne] ; Michel Haissaguerre [France] ; Franciszek Walczak [Pologne] | Ablation of Severe Drug‐Resistant Tachyarrhythmia During Pregnancy |
| 000832 (2010) |
M. Kaye Trembath [Australie] ; Zoë A. Horton [Australie] ; Lynette Tippett [Nouvelle-Zélande] ; Virginia Hogg [Nouvelle-Zélande] ; Veronica R. Collins [Australie] ; Andrew Churchyard [Australie] ; Dennis Velakoulis [Australie] ; Richard Roxburgh [Nouvelle-Zélande] ; Martin B. Delatycki [Australie] | A retrospective study of the impact of lifestyle on age at onset of Huntington disease |
| 000841 (2010) |
Barry J. Snow [Nouvelle-Zélande] ; Fiona L. Rolfe [Nouvelle-Zélande] ; Michelle M. Lockhart [Nouvelle-Zélande] ; Christopher M. Frampton [Nouvelle-Zélande] ; John D. O'Sullivan [Australie] ; Victor Fung [Australie] ; Robin A. J. Smith [Nouvelle-Zélande] ; Michael P. Murphy [Royaume-Uni] ; Kenneth M. Taylor [Nouvelle-Zélande] | A double‐blind, placebo‐controlled study to assess the mitochondria‐targeted antioxidant MitoQ as a disease‐modifying therapy in Parkinson's disease |
| 000886 (2009) |
Rachel Chee [Australie] ; Anna Murphy [Australie] ; Mary Danoudis [Australie] ; Nellie Georgiou-Karistianis [Australie] ; Robert Iansek [Australie] | Gait freezing in Parkinson's disease and the stride length sequence effect interaction |
| 000905 (2009) |
Mark D. Latt ; Hylton B. Menz ; Victor S. Fung ; Stephen R. Lord [Australie] | Acceleration Patterns of the Head and Pelvis During Gait in Older People With Parkinson's Disease: A Comparison of Fallers and Nonfallers |
| 000906 (2009) |
M. Selikhova [Royaume-Uni, Russie] ; D. R. Williams [Royaume-Uni, Australie] ; P. A. Kempster [Royaume-Uni, Australie] ; J. L. Holton [Royaume-Uni] ; T. Revesz [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | A clinico-pathological study of subtypes in Parkinson's disease |
| 000930 (2009) |
Laura Silveira-Moriyama [Royaume-Uni] ; Aviva Petrie [Royaume-Uni] ; David R. Williams [Australie] ; Andrew Evans [Australie] ; Regina Katzenschlager [Autriche] ; Egberto R. Barbosa [Brésil] ; Andrew Lees (neurologue) [Royaume-Uni] | The use of a color coded probability scale to interpret smell tests in suspected parkinsonism |
| 000973 (2009) |
Linda Truong [Australie] ; Daniel Brooks [Australie] ; Fabricio Amaral [Australie] ; Jasmine M. Henderson [Australie] ; Glenda M. Halliday [Australie] | Relative preservation of thalamic centromedian nucleus in parkinsonian patients with dystonia |
| 000A32 (2009) |
Prachi Mehta [Australie] ; George D. Mellick [Australie] ; Dominic B. Rowe [Australie] ; Glenda M. Halliday [Australie] ; Michael M. Jones [Australie] ; Neil Manwaring [Australie] ; Himesha Vandebona [Australie] ; Peter A. Silburn [Australie] ; Jie Jin Wang [Australie] ; Paul Mitchell [Australie] ; Carolyn M. Sue [Australie] | Mitochondrial DNA haplogroups J and K are not protective for Parkinson's disease in the Australian community |
| 000A62 (2009) |
Andrew H. Evans [Australie] ; Antonio P. Strafella [Canada] ; Daniel Weintraub [États-Unis] ; Mark Stacy [États-Unis] | Impulsive and compulsive behaviors in Parkinson's disease |
| 000A71 (2009) |
Greg T. Sutherland [Australie] ; Gerhard A. Siebert [Australie] ; Jeremy R. B. Newman [Australie] ; Peter A. Silburn [Australie] ; Richard S. Boyle [Australie] ; John D. O'Sullivan [Australie] ; George D. Mellick [Australie] | Haplotype analysis of the PARK 11 gene, GIGYF2, in sporadic Parkinson's disease |
| 000A76 (2009) |
Ming-Jen Lee [Taïwan] ; Ignacio F. Mata [États-Unis] ; Chin-Hsien Lin [Taïwan] ; Kai-Yuan Tzen [Taïwan] ; Sarah J. Lincoln [États-Unis] ; Rebecca Bounds [États-Unis] ; Paul J. Lockhart [Australie] ; Mary M. Hulihan [États-Unis] ; Matthew J. Farrer [États-Unis] ; Ruey-Meei Wu [Taïwan] | Genotype–phenotype correlates in Taiwanese patients with early‐onset recessive parkinsonism |
| 000B10 (2009) |
Rogan B. Tinsley [Australie] ; Chris R. Bye [Australie] ; Clare L. Parish [Australie] ; Angela Tziotis-Vais [Australie] ; Sonia George [Australie] ; Janetta G. Culvenor [Australie] ; Qiao-Xin Li [Australie] ; Colin L. Masters [Australie] ; David I. Finkelstein [Australie] ; Malcolm K. Horne [Australie] | Dopamine D2 receptor knockout mice develop features of Parkinson disease |
| 000B11 (2009) |
Greg T. Sutherland [Australie] ; Glenda M. Halliday [Australie] ; Peter A. Silburn [Australie] ; Frank L. Mastaglia [Australie] ; Dominic B. Rowe [Australie] ; Richard S. Boyle [Australie] ; John D. O'Sullivan [Australie] ; Tina Ly [Australie] ; Steve D. Wilton [Australie] ; George D. Mellick [Australie] | Do polymorphisms in the familial Parkinsonism genes contribute to risk for sporadic Parkinson's disease? |
| 000B27 (2009) |
Mario Congiu ; Maurice L. Mashford ; John L. Slavin [Australie] ; Paul V. Desmond | Coordinate regulation of metabolic enzymes and transporters by nuclear transcription factors in human liver disease |
| 000B43 (2009) |
A H Evans [Australie, Royaume-Uni] ; A D Lawrence [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Changes in psychomotor effects of L-dopa and methylphenidate after sustained dopaminergic therapy in Parkinson’s disease |
| 000B77 (2009) |
Meg E. Morris [Australie] ; Robert Iansek [Australie] ; Beth Kirkwood [Australie] | A randomized controlled trial of movement strategies compared with exercise for people with Parkinson's disease |
| 000C53 (2008) |
Mariese A. Hely [Australie] ; Wayne G. J. Reid [Australie] ; Michael A. Adena [Australie] ; Glenda M. Halliday [Australie] ; John G. L. Morris [Australie] | The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years |
| 000C91 (2008) |
Linton J. Meagher [Australie] ; Ralf Ilchef [Australie] ; Paul Silberstein [Australie] ; Raymond J. Cook [Australie] ; Daniel Wasson [Australie] ; Gin S. Malhi [Australie] | Psychiatric morbidity in patients with Parkinson’s disease following bilateral subthalamic deep brain stimulation: literature review |
| 000D28 (2008) |
Sean S. O'Sullivan [Royaume-Uni] ; David R. Williams [Royaume-Uni, Australie] ; David A. Gallagher [Royaume-Uni] ; Luke A. Massey [Royaume-Uni] ; Laura Silveira-Moriyama [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] | Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study |
